As many people express concern over high drug prices, an increasing number of companies have emerged claiming to be their champions against Big Pharma.

Yet pharmacy benefit managers, also known as PBMs, who are tasked with negotiating drug prices with drug manufacturers, have faced bipartisan accusations that they are the ones who contribute to increased list prices for important drugs. PBMs have pushed back against these accusations.